Review Article

Predictors of Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease

A. Barré; J.-F. Colombel; R. Ungaro


Aliment Pharmacol Ther. 2018;47(7):896-905. 

In This Article


A literature search was conducted to identify relevant studies that addressed predictors response to vedolizumab and ustekinumab in IBD. PubMed was searched for all articles published until September 2017, using the key words: inflammatory bowel disease, Crohn's disease, ulcerative colitis, vedolizumab, Entyvio, ustekinumab, Stelara, IL12, IL23, response and predictors of response. References from selected papers were also reviewed. Studies only published as abstracts or not in English were excluded.